Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00070278 Information provided by National Cancer Institute (NCI)

First Received: October 3, 2003 Last Updated: February 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)